Meningococcal vaccination in patients with newly diagnosed asplenia in the United States

Abstract

Meningococcal vaccination rates among newly diagnosed asplenia patients were low, highlighting the need to educate providers about the recommendations for high-risk conditions and ensure healthcare access for vulnerable patients.